US Patent 11298264 Intraocular shunt implantation
Patent 11298264 was granted and assigned to AqueSys on April, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christopher Horvath0
Laszlo O. Romoda0
Richard A. Lewis0
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112982640
Date of Patent
April 12, 2022
0Patent Application Number
165094580
Date Filed
July 11, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 20 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 18 May, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+429 characters)
US Patent 11298264 Intraocular shunt implantation
Article
Glaucoma can be treated by implanting an intraocular shunt in the eye. The implantation can be performed by first determining an entry area below a corneal limbus of an eye. Thereafter, the intraocular shunt can be inserted into eye tissue through the entry area such that an inflow end of the shunt is positioned in the anterior chamber of the eye and an outflow end of the shunt is positioned between layers of Tenon's capsule.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11298264
Date of patent
April 12, 2022
Patent application number
16509458
Date Filed
July 11, 2019
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11298264 Intraocular shunt implantation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.